Literature DB >> 35809175

STAT3 mediates RCP-induced cancer cell invasion through the NF-κB/Slug/MT1-MMP signaling cascade.

Su Jin Cho1, Bo Young Jeong1,2, Young Soo Song3, Chang Gyo Park1, Do Yeun Cho4, Hoi Young Lee5.   

Abstract

Rab coupling protein (RCP) has been known to induce cancer invasion and metastasis, and STAT3 is one of major oncogenic factors. In the present study, we identify the critical role of STAT3 in RCP-induced cancer cell invasion. Immunohistochemical data of ovarian cancer tissues presented that levels of RCP expression are closely correlated with those of phospho-STAT3 (p-STAT3). In addition, ovarian cancer patients with high expression of both RCP and p-STAT3 had significantly lower progress-free and overall survival rates compared to those with low either RCP or p-STAT3 expression. Mechanistically, RCP induced STAT3 phosphorylation in both ovarian and breast cancer cells. Silencing or pharmacological inhibition of STAT3 significantly inhibited RCP-induced cancer cell invasion. In addition, we provide evidence that the β1 integrin/EGFR axis is important for RCP-induced STAT3 phosphorylation. Furthermore, STAT3 activated NF-κB for Slug expression that in turn upregulated MT1-MMP expression for cancer cell invasion. Collectively, our present data demonstrate that STAT3 is located downstream of the β1 integrin/EGFR axis and induces Slug and MT1-MMP expression for cancer cell invasion.
© 2022. The Pharmaceutical Society of Korea.

Entities:  

Keywords:  Cancer cell invasion; MT1-MMP; Rab coupling protein; STAT3; Slug

Mesh:

Substances:

Year:  2022        PMID: 35809175     DOI: 10.1007/s12272-022-01396-0

Source DB:  PubMed          Journal:  Arch Pharm Res        ISSN: 0253-6269            Impact factor:   6.010


  40 in total

Review 1.  Rab25 and RCP in cancer progression.

Authors:  Kyung Hwa Cho; Hoi Young Lee
Journal:  Arch Pharm Res       Date:  2019-02-14       Impact factor: 4.946

Review 2.  EMT, cell plasticity and metastasis.

Authors:  Christine L Chaffer; Beatriz P San Juan; Elgene Lim; Robert A Weinberg
Journal:  Cancer Metastasis Rev       Date:  2016-12       Impact factor: 9.264

3.  Increased expression of Rab coupling protein in squamous cell carcinoma of the head and neck and its clinical significance.

Authors:  Yaozhang Dai; Yong Liu; Donghai Huang; Changyun Yu; Gengming Cai; Leiming Pi; Caiping Ren; Georgia Z Chen; Yongquan Tian; Xin Zhang
Journal:  Oncol Lett       Date:  2012-03-23       Impact factor: 2.967

4.  The YB-1/EZH2/amphiregulin signaling axis mediates LPA-induced breast cancer cell invasion.

Authors:  Kyung Hwa Cho; Bo Young Jeong; Chang Gyo Park; Hoi Young Lee
Journal:  Arch Pharm Res       Date:  2019-04-19       Impact factor: 4.946

Review 5.  Therapeutic implications of cancer epithelial-mesenchymal transition (EMT).

Authors:  Eunae Sandra Cho; Hee Eun Kang; Nam Hee Kim; Jong In Yook
Journal:  Arch Pharm Res       Date:  2019-01-16       Impact factor: 4.946

6.  Requirement of matrix metalloproteinase-9 for the transformation of human mammary epithelial cells by Stat3-C.

Authors:  Tobias N Dechow; Laura Pedranzini; Andrea Leitch; Kenneth Leslie; William L Gerald; Irina Linkov; Jacqueline F Bromberg
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-12       Impact factor: 11.205

Review 7.  Strategies and Approaches of Targeting STAT3 for Cancer Treatment.

Authors:  Steffanie L Furtek; Donald S Backos; Christopher J Matheson; Philip Reigan
Journal:  ACS Chem Biol       Date:  2016-01-15       Impact factor: 5.100

8.  Cancer of the ovary, fallopian tube, and peritoneum.

Authors:  Jonathan S Berek; Sean T Kehoe; Lalit Kumar; Michael Friedlander
Journal:  Int J Gynaecol Obstet       Date:  2018-10       Impact factor: 3.561

9.  RCP induces FAK phosphorylation and ovarian cancer cell invasion with inhibition by curcumin.

Authors:  So Ra Choe; Yu Na Kim; Chang Gyo Park; Kyung Hwa Cho; Do Yeun Cho; Hoi Young Lee
Journal:  Exp Mol Med       Date:  2018-04-27       Impact factor: 8.718

10.  Expression of thymidylate synthase in gastric cancer patients treated with 5-fluorouracil and doxorubicin-based adjuvant chemotherapy after curative resection.

Authors:  J Choi; H Lim; D K Nam; H S Kim; D Y Cho; J W Yi; H C Kim; Y K Cho; M W Kim; H J Joo; K B Lee; K B Kim
Journal:  Br J Cancer       Date:  2001-01       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.